Cigna Group $CI Shares Purchased by Wilsey Asset Management Inc.

Wilsey Asset Management Inc. increased its holdings in shares of Cigna Group (NYSE:CI) by 9.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 121,044 shares of the health services provider’s stock after buying an additional 10,243 shares during the quarter. Cigna Group accounts for about 5.1% of Wilsey Asset Management Inc.’s portfolio, making the stock its 13th largest position. Wilsey Asset Management Inc.’s holdings in Cigna Group were worth $32,289,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Banco Bilbao Vizcaya Argentaria S.A. grew its stake in shares of Cigna Group by 13.5% during the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock worth $9,839,000 after purchasing an additional 4,066 shares during the period. Distillate Capital Partners LLC increased its holdings in shares of Cigna Group by 19.1% during the 3rd quarter. Distillate Capital Partners LLC now owns 108,676 shares of the health services provider’s stock valued at $31,338,000 after purchasing an additional 17,442 shares in the last quarter. Cooperman Leon G lifted its stake in shares of Cigna Group by 53.3% in the 3rd quarter. Cooperman Leon G now owns 325,000 shares of the health services provider’s stock valued at $93,681,000 after purchasing an additional 113,000 shares during the period. Schroder Investment Management Group lifted its stake in shares of Cigna Group by 53.0% in the 3rd quarter. Schroder Investment Management Group now owns 190,710 shares of the health services provider’s stock valued at $54,972,000 after purchasing an additional 66,090 shares during the period. Finally, apricus wealth LLC boosted its holdings in Cigna Group by 715.9% during the fourth quarter. apricus wealth LLC now owns 9,505 shares of the health services provider’s stock worth $2,616,000 after buying an additional 8,340 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Performance

NYSE:CI opened at $287.50 on Monday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $76.05 billion, a PE ratio of 12.19, a P/E/G ratio of 1.11 and a beta of 0.29. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $323.10. The company has a fifty day moving average of $285.09 and a two-hundred day moving average of $279.26.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the business earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, research analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s payout ratio is presently 26.45%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on CI shares. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and cut their price objective for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Mizuho increased their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. Wells Fargo & Company lifted their price target on Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Finally, Guggenheim upped their price target on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $338.30.

Insider Activity

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.